SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-24-000375
Filing Date
2024-05-14
Accepted
2024-05-14 16:39:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4723
  Complete submission text file 0001968582-24-000375.txt   6365
Mailing Address ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119
Business Address
GUYER DAVID R (Reporting) CIK: 0001277476 (see all company filings)

Type: 144

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-51122 | Film No.: 24945141
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)